We are live on ! Find out more
PMD

Psychemedics Corporation
PMD

Delisted

PMD was delisted on the 12th of December, 2024.

Back to rankings

28 hedge funds and large institutions have $13.9M invested in Psychemedics Corporation in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more capital invested

Capital invested by funds: $12.4M → $13.9M (+$1.54M)

0% more funds holding

Funds holding: 28 → 28 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

22% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 9

Holders
28
Holders Change
–
Holders Change %
0%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
7
Reduced
9
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
ICM
Invenomic Capital Management
Massachusetts
+$100K
2
HWM
HighMark Wealth Management
Minnesota
+$40.3K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$9.35K
4
PPA
Parametric Portfolio Associates
Washington
+$6.47K
5
LPL Financial
LPL Financial
California
+$1.91K

Top Sellers

1
TCM
Tieton Capital Management
Washington
-$613K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$282K
3
Renaissance Technologies
Renaissance Technologies
New York
-$79.8K
4
CIC
Crawford Investment Counsel
Georgia
-$76.9K
5
UBS Group
UBS Group
Switzerland
-$11.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$3.14M -$79.8K -10,900 -3%
CIC
2
Crawford Investment Counsel
Georgia
$2.36M -$76.9K -10,498 -4%
Vanguard Group
3
Vanguard Group
Pennsylvania
$2.08M -$7.9K -1,078 -0.4%
RC
4
RBF Capital
California
$1.21M – – –
ICM
5
Invenomic Capital Management
Massachusetts
$1.06M +$100K +13,661 +12%
AA
6
Ancora Advisors
Ohio
$819K – – –
BlackRock
7
BlackRock
New York
$752K +$22 +3 +0%
Dimensional Fund Advisors
8
Dimensional Fund Advisors
Texas
$648K -$282K -38,442 -34%
TCM
9
Tieton Capital Management
Washington
$505K -$613K -83,754 -58%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$294K +$9.35K +1,277 +4%
SMP
11
Santa Monica Partners
Florida
$168K – – –
Northern Trust
12
Northern Trust
Illinois
$165K +$300 +41 +0.2%
LAM
13
Lapides Asset Management
Connecticut
$137K -$2.93K -400 -2%
State Street
14
State Street
Massachusetts
$135K – – –
PPA
15
Parametric Portfolio Associates
Washington
$124K +$6.47K +883 +6%
William Blair & Company
16
William Blair & Company
Illinois
$113K -$3.66K -500 -4%
LPL Financial
17
LPL Financial
California
$95K +$1.91K +260 +2%
Morgan Stanley
18
Morgan Stanley
New York
$52K – – –
HWM
19
HighMark Wealth Management
Minnesota
$46K +$40.3K +5,500 New
NFG
20
Next Financial Group
Texas
$21K – – –
UBS Group
21
UBS Group
Switzerland
$9K -$11.9K -1,625 -58%
NSIM
22
North Star Investment Management
Illinois
$8K – – –
Wells Fargo
23
Wells Fargo
California
$2K +$1.85K +253 +744%
Fidelity Investments
24
Fidelity Investments
Massachusetts
$1K – – –
NFSG
25
Newbridge Financial Services Group
Florida
$1K – – –
1
2

PMD Hedge Fund Activity: Q3 2021 in Review

28 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Psychemedics Corporation (PMD) for Q3 2021, worth a combined $13.9M — up 12% from $12.4M a quarter earlier.

Fund positioning in PMD was balanced in Q3 2021: 1 fund opened new positions, 1 closed out, 7 added to existing stakes and 9 trimmed.

The largest buyer was Invenomic Capital Management, adding an estimated $100K. The largest seller was Tieton Capital Management, cutting an estimated $613K.

  • 28 institutional investors held Psychemedics Corporation (PMD) as of Q3 2021, unchanged from Q2 2021.
  • Funds reported $13.9M of Psychemedics Corporation stock for Q3 2021, up 12% quarter-over-quarter.
  • 1 fund opened new Psychemedics Corporation positions in Q3 2021 and 1 closed out, a net change of 0 holders.
  • The largest Psychemedics Corporation buyer in Q3 2021 was Invenomic Capital Management, an estimated $100K added.
  • The largest Psychemedics Corporation seller in Q3 2021 was Tieton Capital Management, an estimated $613K sold.

Based on aggregated 13F filings for Q3 2021.